Evidence map›Paper›PMID 33380789›Full record

ArticleDrug design, development and therapy2020

Simultaneous Quantitative Analysis of Six Proton-Pump Inhibitors with a Single Marker and Evaluation of Stability of Investigated Drugs in Polypropylene Syringes for Continuous Infusion Use.

Fuchao Chen, Xudong He, Baoxia Fang, Sicen Wang

Abstract read
In one paragraph

Article in Drug design, development and therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. A Fast and Validated HPLC Method for the Simultaneous Analysis of Five 5-HTInternational journal of analytical chemistry · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Fuchao Chen *School of Pharmacy, Xi'an Jiaotong University, Xi'an, Shanxi 710061, People's Republic of China.
Xudong He *Affiliated Dongfeng Hospital, Hubei University of Medicine, Shiyan, Hubei 442008, People's Republic of China.
Baoxia FangAffiliated Dongfeng Hospital, Hubei University of Medicine, Shiyan, Hubei 442008, People's Republic of China.
Sicen WangSchool of Pharmacy, Xi'an Jiaotong University, Xi'an, Shanxi 710061, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveWe developed and validated a simple, convenient and reproducible method for simultaneous estimation of six proton-pump inhibitors (PPIs), omeprazole (OPZ), esomeprazole (EOPZ), lansoprazole (LPZ), pantoprazole (PPZ), rabeprazole (RPZ) and ilaprazole (IPZ) in pharmaceutical dosage forms by a single marker. Meanwhile, the stability of the cited PPIs in 0.9% sodium chloride injection stored in polypropylene syringes up to 48 hours for continuous infusion use was investigated. MATERIALS AND

methodsThe chromatographic separation was achieved on an InterSustain

resultsUnder these conditions, all cited PPIs were separated simultaneously at a retention time of 6.0, 7.3, 7.3, 9.9, 12.5 and 13.9 min for RPZ, OPZ, EOPZ, IPZ, PPZ and LPZ, respectively, with a total run time less than 20.0 min. Comparative analysis results indicated that there were no significant differences observed between the QAMS method and the external standard method. The percentage of initial concentration of each PPI gradually decreased during the storage time.

conclusionThe proposed method, which is selective, economical and accurate, was applied successfully for determination of the cited PPIs in their respective pharmaceutical dosage forms. Admixtures of OPZ, EOPZ, PPZ, IPZ in 0.9% sodium chloride injection were stable for 24 hours and LPZ, RPZ in 0.9% sodium chloride injection were stable for 8 hours in polypropylene syringes.

Indexed as

2-PyridinylmethylsulfinylbenzimidazolesChromatography, High Pressure LiquidDrugs, InvestigationalEsomeprazoleHumansLansoprazoleMolecular StructureOmeprazolePantoprazolePolypropylenesProton Pump InhibitorsRabeprazole2-PyridinylmethylsulfinylbenzimidazolesDrugs, InvestigationalEsomeprazoleilaprazoleLansoprazoleOmeprazolePantoprazolePolypropylenesProton Pump InhibitorsRabeprazoleHPLCproton-pump inhibitorsquantitative analysis of multi-components with a single markerrelative correction factorrelative retention timestability

Identifiers

PMID33380789
PMCPMC7769080

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.